Skip Navigation

Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors FHWT

Brief Summary

Type:
Kidney

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT06401330

Study #:
CMH - AREN2231

Start Date:
May 05, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06401330

View Complete Trial Details & Eligibility at ClinicalTrials.gov